Affiliation:
1. Departamento de Química Física, Facultad de Ciencias Ambientales y Bioquímica and INAMOL, Universidad de Castilla-La Mancha, Av. Carlos III, s/n, 45071 Toledo, Spain
Abstract
Monitoring the biological fate of medicaments within the environments of cancer cells is an important challenge which is nowadays the object of intensive studies. In this regard, rhodamine-based supramolecular systems are one of the most suitable probes used in drug delivery thanks to their high emission quantum yield and sensitivity to the environment which helps to track the medicament in real time. In this work, we used steady-state and time-resolved spectroscopy techniques to investigate the dynamics of the anticancer drug, topotecan (TPT), in water (pH ~6.2) in the presence of a rhodamine-labeled methylated β-cyclodextrin (RB-RM-βCD). A stable complex of 1:1 stoichiometry is formed with a Keq value of ~4 × 104 M−1 at room temperature. The fluorescence signal of the caged TPT is reduced due to: (1) the CD confinement effect; and (2) a Förster resonance energy transfer (FRET) process from the trapped drug to the RB-RM-βCD occurring in ~43 ps with 40% efficiency. These findings provide additional knowledge about the spectroscopic and photodynamic interactions between drugs and fluorescent functionalized CDs, and may lead to the design of new fluorescent CD-based host–guest nanosystems with efficient FRET to be used in bioimaging for drug delivery monitoring.
Reference105 articles.
1. Alhmoud, J.F., Woolley, J.F., Al Moustafa, A.-E., and Malki, M.I. (2020). DNA Damage/Repair Management in Cancers. Cancers, 12.
2. Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis;Bruzzese;Mol. Cancer Ther.,2009
3. Topotecan—A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience;Kollmannsberger;Oncology,1999
4. Review of the use of topotecan in ovarian carcinoma;Ahmad;Expert Opin. Pharmacother.,2004
5. Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer;Mirchandani;Clin. Cancer Res.,2005
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献